CEO Sells 80,000 MEDIROM Shares “For No Consideration” Amid Quiet Q2—Is a Capital‑Raising Move on the Horizon?
CEO’s August sale of 80k shares at $0.95 hints at a strategic shift, yet MEDIROM’s HealthTech growth and salon expansion may still turn investor confidence upside‑down.
3 minutes to read